Antipyrine as a model drug to study hepatic drug-metabolizing capacity
Henrik E. Poulsen , Steffen Loft
Abstract
Similar articles
IF:5
Albumin nanostructures as advanced drug delivery systems.
Expert Opinion on Drug Delivery
Mahdi Karimi,?Sajad Bahrami,etc
Published: 1 November 2016
IF:56.7
Aprepitant: drug–drug interactions in perspective
Annals of Oncology
M.S. Aapro , C.M. Walko,etc
Published: 1 December 2010
IF:0
Avanafil: A comprehensive drug profile.
Profiles of drug substances, excipients, and related methodology
Abdulrahman A Al-Majed,?Amer AlKhairallah,etc
Published: 1 January 2024
Latest Papers
Antipyrine as a model drug to study hepatic drug-metabolizing capacity
Published: 1 January 1988